Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
about
Safety and Efficacy of Microinvasive Glaucoma SurgeryFixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for GlaucomaEP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover studyEfficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprostPrescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study.PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDATIONS IN AUSTRALIA.Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertensionEffects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomyOcular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.
P2860
Q33645481-98012E6F-899A-4F44-BA43-B8B8ECA05A82Q36239886-510A8385-1D3C-44A3-B7EE-A9AE8B7B6AB5Q36626793-8F7DE9CA-B0DF-452A-B654-E50A44832A31Q36968704-B04EDEF6-52AB-4307-80F9-925EAB3E3DAFQ37376684-F8D14C10-EDF1-45E7-A0B0-E0EE2C61A5B2Q38670926-60DF888C-13E4-41D2-A62E-789E6A12FE77Q38681395-784791EF-C816-41AF-A5BA-3480BD1C234BQ38934012-4C275DC2-EB9F-48BF-9E12-E4758F7D4F74Q39831161-009ABC33-BCC8-4688-BC10-B40D1A91914EQ41072167-0A1E34FD-DAD0-4946-8CA6-33180829F408Q42280470-E6328467-E8D6-498B-89CC-7722987952ADQ45462727-6C092C9C-33C6-4488-ABD6-70E96AFB66D8Q47381165-1EDAAC58-4504-44AD-A725-B479B0FDBDEBQ53827949-AE93AAAD-9F2F-439D-A54A-D18EBEC9728B
P2860
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@ast
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@en
type
label
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@ast
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@en
prefLabel
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@ast
Comparative efficacy and toler ...... ucoma and ocular hypertension.
@en
P2093
P2860
P356
P1476
Comparative efficacy and toler ...... aucoma and ocular hypertension
@en
P2093
Ai Leng Khoo
Boon Peng Lim
Dianne Bautista
Hon-Tym Wong
Monica Teng
Paul T K Chew
Tuck Seng Wu
Ying Jiao Zhao
P2860
P304
P356
10.1177/1060028014548569
P407
P577
2014-09-02T00:00:00Z